Condition
Locally Recurrent Rectal Cancer
Total Trials
4
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (2)
Trial Status
Recruiting2
Active Not Recruiting1
Not Yet Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07183865Phase 2RecruitingPrimary
Hypofractionated Radiotherapy Combined With NALIRIF, PD-1 Antibody in Locally Recurrent Rectal Cancer(NOVELTY-R)
NCT05877352Not ApplicableActive Not Recruiting
Intraoperative Electron Radiotherapy in Rectal Cancer - A Feasibility Trial
NCT06928584Phase 2RecruitingPrimary
Hypofractionated Radiotherapy Plus Immunotherapy Versus Conventional Radiotherapy in Locally Recurrent Rectal Cancer
NCT06617052Not Yet RecruitingPrimary
Preoperative (Chemo)Radiotherapy for Locally Recurrent Rectal Cancer
Showing all 4 trials